ImaginAb, Inc. is an early-stage biotechnology company specializing in the development of engineered antibody fragments for diagnostic imaging and radioimmunotherapy.  We have a pipeline of clinical imaging agents under clinical development addressing unmet needs in cancer and immunology diagnostic imaging.  ImaginAb is also developing a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT and optical systems and partners on a selective basis with biopharmaceutical companies with an interest in developing companion imaging agents for therapeutic antibody product development.

ImaginAb’s technology was developed at UCLA and the Beckman Institute at the City of Hope by founders Dr. Anna Wu and Dr. Rob Reiter.  ImaginAb is located in Inglewood, CA just a few miles from UCLA and we leverage a strong working relationship with our founding institutions along with other regional healthcare and research organizations. 

As we grow we remain focused on serving unmet needs through targeted research, imaging and diagnostics.